Taylor Matlas, DO | |
1 Mellon Way, Latrobe, PA 15650-1197 | |
(724) 537-1000 | |
Not Available |
Full Name | Taylor Matlas |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 1 Mellon Way, Latrobe, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932890852 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OT022309 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Taylor Matlas, DO 6943 Spring Valley Ln, Export, PA 15632-2644 Ph: (724) 771-2860 | Taylor Matlas, DO 1 Mellon Way, Latrobe, PA 15650-1197 Ph: (724) 537-1000 |
News Archive
Delay in initiation of therapeutic hypothermia and delay in return of spontaneous circulation (ROSC), evidenced by a palpable pulse or a measurable blood pressure, were both associated with poor neurologic outcomes in post cardiac arrest patients, according to a study being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla.
Noting a recent U.N. study showed that, despite progress on tackling child mortality globally, sub-Saharan Africa "is trailing far behind," David Dominic, a consultant for non-governmental organizations, writes in this Huffington Post U.K. opinion piece, "The more we look, the more it seems that the U.K. aid system, with regards to sub-Saharan Africa, is carefully designed to control and exploit the region, with scant regard for the impacts upon the poor. That is, aid seems to be used as a tool of modern imperialism."
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that presentations of clinical data for three product candidates employing its Targeted Antibody Payload (TAP) technology will be made at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition to be held in New Orleans, LA, on December 5-8, 2009.
Advanced Cell Technology, Inc. announced today that human embryonic stem cell line MA135 was unanimously approved for federal funding at the 100th Meeting of the Advisory Committee to the Director National Institutes of Health. In addition to MA135, seven additional stem cell lines derived at ACT are currently under review by the NIH.
A new study has shown that fat cells could be implicated in the transformation of the melanoma cells in the skin into highly malignant cells that spread to the different organs of the body. A team from the Tel Aviv University, led by Prof. Carmit Levy and Dr. Tamar Golan of the Department of Human Genetics and Biochemistry at TAU's Sackler School of Medicine published their findings in the journal Science Signaling this week.
› Verified 1 days ago
Jacob Edward Oslosky, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-961-0359 | |
Luke Egan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 | |
Dr. Christopher C. Drescher, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 | |
Karren Vlahos, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1207 | |
Emily Katherine Fellin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mellon Way, Latrobe Family Medicine Residency Program, Latrobe, PA 15650 Phone: 724-537-1485 | |
Dr. Francis E Meyers, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Route 217, Suite 5, Latrobe, PA 15650 Phone: 724-694-0274 Fax: 724-694-0383 | |
Dr. Anna Nash Gorman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 |